User profiles for S. M. Lobo

Suzana M Lobo

Faculdade de Medicina de São José do Rio Preto - Hospital de Base
Verified email at famerp.br
Cited by 13862

Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial

…, V Pettilä, X Wittebole, F Meziani, E Mercier, SM Lobo… - Jama, 2019 - jamanetwork.com
… Dr Lobo reported receiving personal fees for the conduct of the study as the principal
investigator at FUNFARME. Dr Barie reported personal fees from AKPA America during the conduct …

Randomized trial of molnupiravir or placebo in patients hospitalized with Covid-19

JR Arribas, S Bhagani, SM Lobo, I Khaertynova… - NEJM …, 2022 - evidence.nejm.org
Background Molnupiravir is an oral prodrug of β-D-N4-hydroxycytidine, active against SARS-CoV-2
in vitro and in animal models. We report data from the phase 2 component of MOVe-…

[HTML][HTML] Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind …

…, JFK Saraiva, G Marx, SM Lobo… - The Lancet …, 2022 - thelancet.com
Background Vilobelimab, an anti-C5a monoclonal antibody, was shown to be safe in a
phase 2 trial of invasively mechanically ventilated patients with COVID-19. Here, we aimed to …

[HTML][HTML] Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

IO Rosas, G Diaz, RL Gottlieb, SM Lobo… - Intensive care …, 2021 - Springer
Purpose Trials of tocilizumab in patients with severe COVID-19 pneumonia have
demonstrated mixed results, and the role of tocilizumab in combination with other treatments is …

Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study

…, JL Nates, U Jaschinski, SM Lobo… - The Lancet …, 2021 - thelancet.com
Background End-of-life practices vary among intensive care units (ICUs) worldwide.
Differences can result in variable use of disproportionate or non-beneficial life-sustaining …

[HTML][HTML] Noninvasive ventilation immediately after extubation improves weaning outcome after acute respiratory failure: a randomized controlled trial

SR Ornico, SM Lobo, HS Sanches, M Deberaldini… - Critical Care, 2013 - Springer
Introduction Noninvasive ventilation (NIV), as a weaning-facilitating strategy in predominantly
chronic obstructive pulmonary disease (COPD) mechanically ventilated patients, is …

Evaluation and initial management of acute kidney injury

…, R Prielipp, CR Parikh, N Pannu, SM Lobo… - Clinical Journal of the …, 2008 - journals.lww.com
The evaluation and initial management of patients with acute kidney injury (AKI) should
include:(1) an assessment of the contributing causes of the kidney injury,(2) an assessment of …

Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model

M Ahmed, Z Liu, KS Afzal, D Weeks, SM Lobo… - Radiology, 2004 - pubs.rsna.org
PURPOSE: To determine the effect of surrounding tissue type on coagulation necrosis from
radiofrequency (RF) ablation in a homogeneous animal tumor model. MATERIALS AND …

[HTML][HTML] Patterns and early evolution of organ failure in the intensive care unit and their relation to outcome

Y Sakr, SM Lobo, RP Moreno, H Gerlach, VM Ranieri… - Critical care, 2012 - Springer
Introduction Recognition of patterns of organ failure may be useful in characterizing the
clinical course of critically ill patients. We investigated the patterns of early changes in organ …

[HTML][HTML] Restrictive strategy of intraoperative fluid maintenance during optimization of oxygen delivery decreases major complications after high-risk surgery

SM Lobo, LS Ronchi, NE Oliveira, PG Brandão… - Critical care, 2011 - Springer
Introduction Optimal fluid management is crucial for patients who undergo major and prolonged
surgery. Persistent hypovolemia is associated with complications, but fluid overload is …